500124:BOM
Dr Reddy's Laboratories Ltd
1.221,00 ₹
arrow_downward
-1,50%(-18,65) 1D
14. okt., 10.04.16 GMT+5.30 · INR
search
Alle symboler
| Symbol | Pris | Ændring | Ændring i % |
|---|
insights_autoGenererer vigtig indsigt for 500124...
Åbn
1.237,35 ₹
Høj
1.237,35 ₹
Lav
1.219,50 ₹
Markedsværdi
1,02 bio.
Gns. vol.
85,80 t
Volumen
12,02 t
Udbytte
0,66 %
Kvartalsvis udbytte
2,00 ₹
Ex-dato
10. jul. 2026
P/E-forhold
31,57
Højeste i 52 uger
1.414,40 ₹
Laveste i 52 uger
1.080,05 ₹
Indtægt pr. aktie
38,67 ₹
Aktier i omløb
166,06 mio.
Antal ansatte
28 t
Åbn
1.237,35 ₹
Høj
1.237,35 ₹
Lav
1.219,50 ₹
Markedsværdi
1,02 bio.
Gns. vol.
85,80 t
Volumen
12,02 t
Udbytte
0,66 %
Kvartalsvis udbytte
2,00 ₹
Ex-dato
10. jul. 2026
P/E-forhold
31,57
Højeste i 52 uger
1.414,40 ₹
Laveste i 52 uger
1.080,05 ₹
Indtægt pr. aktie
38,67 ₹
Aktier i omløb
166,06 mio.
Antal ansatte
28 t
Nyhedshistorier
Fra webkilder og nyhedspartnere
www.marketscreener.com
·
for 1 dag siden
Dr. Reddy's Laboratories Shares Rise After BNP Paribas Upgrade
Profil
Dr. Reddy's Laboratories Ltd. is an Indian multinational pharmaceutical company based in Hyderabad, with U.S. headquarters in East Brunswick, New Jersey. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients for drug manufacture, diagnostic kits, critical care, and biotechnology.
Dr. Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting to less-regulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the U.S. Food and Drug Administration. By the early 1990s, the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants – in more-developed economies. This allowed their movement into regulated markets such as the US and Europe.
By 2007, Dr. Wikipedia
Om Dr Reddy's Laboratories Ltd
Administrerende direktørErez Israeli
Ansatte27,5 t
Grundlagt1984
HovedsædeHyderabad, Andhra Pradesh, Indien
Sektor-
Websitedrreddys.com